Filipazzi Virginio

Adjunct Professor

Contacts

University email address
Research

Publications

Publications
  • Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC) : An Italian, Multicenter, Retrospective Study / A. Luciani, A. Marra, L. Toschi, D. Cortinovis, S. Fava, V. Filipazzi, A. Tuzi, G. Cerea, S. Rossi, V. Perfetti, A. Rossi, L. Giannetta, L. Sala, G. Finocchiaro, E.G. Pizzutilo, S. Carelli, F. Agustoni, M. Cergnul, S. Zonato, S. Siena, P. Bidoli, D. Ferrari. - In: CLINICAL LUNG CANCER. - ISSN 1525-7304. - (2020 May 13). [Epub ahead of print]
  • ABCB1 c.3435C > T polymorphism is associated with platinum toxicity: a preliminary study / B. De Troia, D. Dalu, V. Filipazzi, L. Isabella, N. Tosca, S. Ferrario, A.R. Gambaro, L. Somma, C. Fasola, S. Cheli, E. Clementi, D. De Francesco, F.S. Falvella, M.T. Cattaneo. - In: CANCER CHEMOTHERAPY AND PHARMACOLOGY. - ISSN 0344-5704. - 83:4(2019 Apr), pp. 803-808.
  • Granulocyte colony-stimulating factors used in clinical practice : PoloNord registry-based cohort Italian study / D. Fagnani, L. Isa, M.F. Verga, P. Nova, C. Casartelli, V. Filipazzi, M. Danova, G. Farina, P. Pugliese, S. Fava, A. Bertolini, C. Cimminiello, P. Boracchi, G. Marano, C. Panzarino, POLONORD Group. - In: TUMORI. - ISSN 2038-2529. - 100:5(2014), pp. 491-498.